Join
Live feed
·
PRReleasevia Quantisnow
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting

ByQuantisnow·Wall Street's wire, on your screen.
LIPO· Lipella Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIPO (Lipella Pharmaceuticals Inc.) and more on Quantisnow.